Isabella Plumptre to Treatment Outcome
This is a "connection" page, showing publications Isabella Plumptre has written about Treatment Outcome.
Connection Strength
0.160
-
Plumptre IR, Said JT, Sun T, Larocca C, Virgen CA, Kupper TS, Fisher DC, Devlin PM, Elco CP, Song JS, LeBoeuf NR. Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review. Leuk Lymphoma. 2022 12; 63(12):2832-2846.
Score: 0.090
-
Plumptre I, Stuart G, Cerullo A, Kinsler VA. Sedation for screening MRI in patients with congenital melanocytic naevi under the age of one is a successful, safe and economical first-line approach. Br J Dermatol. 2019 03; 180(3):668-669.
Score: 0.070